PARIS-- (BUSINESS WIRE)--Okomera, a TechBio company pioneering personalized cancer care through a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results